| Literature DB >> 17917098 |
Narin Nasiroğlu1, Merve Pamukçuoğlu, Hüseyin Abali, Berna Oksüzoğlu, Ayşegül Uner, Nurullah Zengin.
Abstract
Tamoxifen has been in the center of management of hormone-sensitive breast cancer. Furthermore, it represents the best example of chemo-prevention: It reduces the incidence of invasive breast cancer. However, it has some side effects, several of them are severe. Oncologists, hematologists, internal medicine specialists and gynecologists must know this agent in detail. Authors report a very rare side effect, thrombocytopenia, and discuss it briefly.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17917098 DOI: 10.1007/s12032-007-0013-0
Source DB: PubMed Journal: Med Oncol ISSN: 1357-0560 Impact factor: 3.064